Search All Applications in Cannabis: Compositions
Application US20200330424
Published 2020-10-22
Cannabinoid Lozenge Formulation
The present invention relates to a lozenge composition for controlled release of cannabinoids comprising; i) a master granule component comprising one or more solid particles and one or more cannabinoids reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the master granule component comprising one or more extragranular sugar alcohols.
Much More than Average Length Specification
View the Patent Matrix® Diagram to Explore the Claim Relationships
USPTO Full Text Publication >
- 1-115. (canceled)
- 116. A lozenge composition for controlled release of cannabinoids comprising:
i) a master granule component comprising one or more solid particles and one or more cannabinoids reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the master granule component comprising one or more extragranular sugar alcohols.
- 138. A lozenge composition for controlled release of cannabinoids comprising:
i) a master granule component comprising a premixture of one or more solid particles and one or more cannabinoids, the one or more cannabinoids being reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the master granule component comprising one or more extragranular sugar alcohols.
- 139. A lozenge composition for controlled release of cannabinoids comprising:
i) a master granule component comprising one or more solid particles and one or more lipid carriers into which one or more cannabinoids are located, the one or more cannabinoids being reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the master granule component comprising one or more extragranular sugar alcohols.
